Life Science Reagents Market Share Analysis Report, 2022-2030
The global Life Science Reagents market size was estimated at USD 54.9 billion in 2021 and is expected to surpass around USD 100.8 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 5.10% during the forecast period 2022 to 2030.
Overview of Life Science Reagents Market
Life science reagents are substances or compounds used in a chemical reaction to observe and record changes. Medical researchers analyze this data to determine the cause of a disease. Life science and analytical reagents are used in chemical reactions to measure, detect, or examine other substances. Technological advancements in molecular biology, life sciences, and biotechnology have brought about significant changes in health care diagnostics, drug discovery, personalized medicines, forensic sciences, and clinical research & development. This has increased the demand for biotechnology media, sera and reagents, biotechnology reagents, etc. Growth of the life science industry and increase in incidence rate of chronic and infectious diseases are driving the global life science reagents market.
Report Scope of the Life Science Reagents Market
|
Report Coverage |
Details |
|
Market Size |
USD 100.8 Billion by 2030 |
|
Growth Rate |
CAGR of 5.10% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Product, End-user And Geography, |
|
Companies Mentioned |
|
Increase in Geriatric Population and Rise in Need for Disease Diagnosis Propel Global Life Science Reagents Market
Advances in the health care industry and life sciences industry, improvement in public health measures, and decrease in life-threatening infectious diseases in developed countries are augmenting the life expectancy of the global geriatric population. According to the United Nations, the elderly population (aged 60+ years) is expected to double by 2050 and triple by 2100. The population is likely to rise from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100. Globally, the geriatric population is growing at a faster rate than the young population. The geriatric population in Asia Pacific and South America is estimated to increase by 300% in the next decade. As part of preventive health care, the geriatric population and people with chronic diseases such as diabetes, respiratory disorders, and cancer regularly require medical tests such as blood tests and urine tests. This is projected to augment the life science reagents market during the forecast period.
Rise in Adoption of Advanced Products to Drive Global Life Science Reagents Market
Development in the areas of enzyme-linked immune assay technology (ELISA), polymerase chain reaction (PCR) such as digital PCR, rtPCR, chromatography, single cell technology, next-generation sequencing (NGS), and flow cytometry techniques; and their application in the health care industry in disease diagnostics and treatment monitoring are propelling the life science reagents market. For instance, the chemiluminescence immunoassay (CLIA) technology provides enhanced sensitivity, specificity, improved precision, and reduced incubation. Together, these increase the efficiency of the technology to diagnose different types of genetic, chronic, acute, and infectious diseases. Technological advancements in point-of-care (POC) instruments for the diagnosis of various chronic and infectious diseases within a short period, development of high throughput automated immunoassay analyzers, and integration of the various diagnostic techniques in a single system are factors fueling the demand for in vitro diagnostics reagents in the health care industry. Advances in genomics and proteomics have led to the development of newer genetic and protein biomarkers for the diagnosis of cancer and several genetic diseases. Genomic studies are also used in pharmacokinetics and targeted therapy to identify infectious diseases by sequencing reagents to diagnose genetic factors that contribute to common diseases and personalized medicines. Increase in application of cell and tissue culture for the production of monoclonal antibodies, drug development, vaccines, enzymes, growth hormones, and stem cell therapy is propelling the demand for life science reagents.
Growth in Prevalence of Chronic and Infectious Diseases to Augment Global Life Science Reagents Market
Diagnosis of infectious and chronic diseases is one of the leading applications of in vitro diagnostics. Life science reagents, both biological and laboratory chemical reagents, are integral part of any diagnostic test. Emergence and outbreak of various infectious diseases have created challenges and new opportunities for researchers to develop life science tools and reagents for early diagnosis and prevention of disease. As of June 2022, coronavirus (COVID-19) has caused 539 million confirmed infections and 6.3 million deaths. The pandemic does not show any sign of abatement. The impact and consequences of the COVID-19 pandemic positively impacted the life science reagents market in 2020 and 2021. Growth of the diagnostics segment, led by Covid-19 testing and continuous research & development conducted by various pharmaceutical & biotechnological companies to develop medicines and vaccines, is likely to drive the life science reagents market during the forecast period.
Popularity of Immunoassay as Diagnostic Tool to Drive Demand for Immunoassay Reagents
In terms of product, the global life science reagents market has been classified into chromatography reagents, molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, flow cytometry reagents, cell & tissue culture reagents, hematology & hemostasis reagents, microbiology reagents, and others. The immunoassay reagents segment dominated the global life science reagents market in 2021. The trend is projected to continue during the forecast period. Immunoassay is a highly preferred diagnostic technique used in hospitals and pathology laboratories. The immunoassay technique is increasingly becoming a popular diagnostic tool owing to specific results, high sensitivity, and ease of use.
High Usage of Life Science Reagents to Propel Hospitals & Diagnostics Laboratories Segment
Based on end-user, the global life science reagents market has been divided into hospitals & diagnostic laboratories, commercial & contract research manufacturers, academic & research institutes, and others. The hospitals & diagnostic laboratories segment dominated the global life science reagents market in 2021 due to the high usage of life science reagents in hospitals and laboratories for the diagnosis of Covid-19.
Regional Outlook of Global Life Science Reagents Market
North America accounted for the largest share of around 35% of the global life science reagents market in 2021. The market in the region is projected to grow at a CAGR of 5.5% from 2022 to 2031. The life science reagents market in Asia Pacific is anticipated to grow at a higher CAGR during the forecast period due to the large patient pool and rise in investment in health care in countries such as China and India.
Analysis of Key Players in Global Life Science Reagents Market
The global life science reagents market is fragmented, with the presence of a large number of key players. Most companies are making significant investments in research & development activities. Expansion of product portfolios and mergers & acquisitions are the key strategies adopted by the players. Key players operating in the market include F. Hoffmann-La Roche AG, Danaher Corporation, Abbott, Siemens Healthineers, DiaSorin S.p.A, Sysmex Corporation, bioMerieux SA, Thermo Fisher Scientific, Inc., BD, Merck KGaA, Agilent Technologies, Inc., and Waters Corporation.
Key Developments in Global Life Science Reagents Market
Some of the prominent players in the Life Science Reagents Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Life Science Reagents market
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits for Stakeholders
Chapter 1. Introduction
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Life Science Reagents Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Life Science Reagents Market Analysis and Forecast,
2017–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Mergers & Acquisitions
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Life Science Reagents Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2030
6.3.1. Chromatography Reagents
6.3.2. Molecular Diagnostic Reagents
6.3.3. Immunoassay Reagents
6.3.4. Clinical Chemistry Reagents
6.3.5. Flow Cytometry Reagents
6.3.6. Cell & Tissue Culture Reagents
6.3.7. Hematology & Hemostasis Reagents
6.3.8. Microbiology Reagents
6.3.9. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Life Science Reagents Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2030
7.3.1. Hospitals & Diagnostics Laboratories
7.3.2. Commercial & Contract Research Manufacturers
7.3.3. Academic & Research Institutes
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Life Science Reagents Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Life Science Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2030
9.2.1. Chromatography Reagents
9.2.2. Molecular Diagnostic Reagents
9.2.3. Immunoassay Reagents
9.2.4. Clinical Chemistry Reagents
9.2.5. Flow Cytometry Reagents
9.2.6. Cell & Tissue Culture Reagents
9.2.7. Hematology & Hemostasis Reagents
9.2.8. Microbiology Reagents
9.2.9. Others
9.3. Market Value Forecast, by End-user, 2017–2030
9.3.1. Hospitals & Diagnostics Laboratories
9.3.2. Commercial & Contract Research Manufacturers
9.3.3. Academic & Research Institutes
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017–2030
9.4.1. US
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Life Science Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2030
10.2.1. Chromatography Reagents
10.2.2. Molecular Diagnostic Reagents
10.2.3. Immunoassay Reagents
10.2.4. Clinical Chemistry Reagents
10.2.5. Flow Cytometry Reagents
10.2.6. Cell & Tissue Culture Reagents
10.2.7. Hematology & Hemostasis Reagents
10.2.8. Microbiology Reagents
10.2.9. Others
10.3. Market Value Forecast, by End-user, 2017–2030
10.3.1. Hospitals & Diagnostics Laboratories
10.3.2. Commercial & Contract Research Manufacturers
10.3.3. Academic & Research Institutes
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Life Science Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2030
11.2.1. Chromatography Reagents
11.2.2. Molecular Diagnostic Reagents
11.2.3. Immunoassay Reagents
11.2.4. Clinical Chemistry Reagents
11.2.5. Flow Cytometry Reagents
11.2.6. Cell & Tissue Culture Reagents
11.2.7. Hematology & Hemostasis Reagents
11.2.8. Microbiology Reagents
11.2.9. Others
11.3. Market Value Forecast, by End-user, 2017–2030
11.3.1. Hospitals & Diagnostics Laboratories
11.3.2. Commercial & Contract Research Manufacturers
11.3.3. Academic & Research Institutes
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user/p>
11.5.3. By Country/Sub-region
12. Latin America Life Science Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2030
12.2.1. Chromatography Reagents
12.2.2. Molecular Diagnostic Reagents
12.2.3. Immunoassay Reagents
12.2.4. Clinical Chemistry Reagents
12.2.5. Flow Cytometry Reagents
12.2.6. Cell & Tissue Culture Reagents
12.2.7. Hematology & Hemostasis Reagents
12.2.8. Microbiology Reagents
12.2.9. Others
12.3. Market Value Forecast By End-user, 2017–2030
12.3.1. Hospitals & Diagnostics Laboratories
12.3.2. Commercial & Contract Research Manufacturers
12.3.3. Academic & Research Institutes
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Life Science Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2030
13.2.1. Chromatography Reagents
13.2.2. Molecular Diagnostic Reagents
13.2.3. Immunoassay Reagents
13.2.4. Clinical Chemistry Reagents
13.2.5. Flow Cytometry Reagents
13.2.6. Cell & Tissue Culture Reagents
13.2.7. Hematology & Hemostasis Reagents
13.2.8. Microbiology Reagents
13.2.9. Others
13.3. Market Value Forecast, by End-user, 2017–2030
13.3.1. Hospitals & Diagnostics Laboratories
13.3.2. Commercial & Contract Research Manufacturers
13.3.3. Academic & Research Institutes
13.3.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. F. Hoffmann-La Roche AG
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Danaher Corporation
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Abbott
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Siemens Healthineers
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. DiaSorin S.p.A
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Sysmex Corporation
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. bioMerieux SA
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Ortho Clinical Diagnostics
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Thermo Fisher Scientific, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. F. Hoffmann-La Roche AG
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Merck KGaA
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Agilent Technologies, Inc.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Waters Corporation
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers